Importo totale (1 articolo articoli):
Destinazione ordine:
khan iftekhar (73 risultati)
Vai alla pagina principale dei risultati di ricerca
Filtri di ricerca
Tipo di articolo
- Tutti i tipi di prodotto
- Libri (73)
- Riviste e Giornali (Nessun altro risultato corrispondente a questo perfezionamento)
- Fumetti (Nessun altro risultato corrispondente a questo perfezionamento)
- Spartiti (Nessun altro risultato corrispondente a questo perfezionamento)
- Arte, Stampe e Poster (Nessun altro risultato corrispondente a questo perfezionamento)
- Fotografie (Nessun altro risultato corrispondente a questo perfezionamento)
- Mappe (Nessun altro risultato corrispondente a questo perfezionamento)
- Manoscritti e Collezionismo cartaceo (Nessun altro risultato corrispondente a questo perfezionamento)
Condizioni Maggiori informazioni
- Nuovo (63)
- Come nuovo, Ottimo o Quasi ottimo (9)
- Molto buono o Buono (1)
- Discreto o Mediocre (Nessun altro risultato corrispondente a questo perfezionamento)
- Come descritto (Nessun altro risultato corrispondente a questo perfezionamento)
Legatura
Ulteriori caratteristiche
- Prima ed. (1)
- Copia autograf. (Nessun altro risultato corrispondente a questo perfezionamento)
- Sovracoperta (Nessun altro risultato corrispondente a questo perfezionamento)
- Con foto (17)
- Non Print on Demand (62)
Lingua (1)
Spedizione gratuita
Paese del venditore
Valutazione venditore
-
Design & Analysis of Clinical Trials for Economic Evaluation & Reimbursement: An Applied Approach Using SAS & Stata
Libro 61 di 155: Chapman & Hall/CRC BiostatisticsDa: ThriftBooks-Dallas, Dallas, TX, U.S.A.
Valutazione del venditore 5 su 5 stelle
Hardcover. Condizione: As New. No Jacket. Pages are clean and are not marred by notes or folds of any kind. ~ ThriftBooks: Read More, Spend Less.
-
Economic Evaluation of Cancer Drugs : Using Clinical Trial and Real World Data
Da: GreatBookPrices, Columbia, MD, U.S.A.
Valutazione del venditore 5 su 5 stelle
Condizione: New.
-
Economic Evaluation of Cancer Drugs
Da: PBShop.store US, Wood Dale, IL, U.S.A.
Valutazione del venditore 5 su 5 stelle
HRD. Condizione: New. New Book. Shipped from UK. Established seller since 2000.
-
Economic Evaluation of Cancer Drugs : Using Clinical Trial and Real World Data
Da: GreatBookPrices, Columbia, MD, U.S.A.
Valutazione del venditore 5 su 5 stelle
Condizione: As New. Unread book in perfect condition.
-
Economic Evaluation of Cancer Drugs
Da: PBShop.store UK, Fairford, GLOS, Regno Unito
Valutazione del venditore 5 su 5 stelle
EUR 48,10
Spedizione EUR 6,80
Spedito da Regno Unito a U.S.A.Quantità: 2 disponibili
Aggiungi al carrelloHRD. Condizione: New. New Book. Shipped from UK. Established seller since 2000.
-
Economic Evaluation of Cancer Drugs
Lingua: Inglese
Editore: Taylor and Francis Inc, US, 2019
ISBN 10: 1498761305 ISBN 13: 9781498761307
Da: Rarewaves.com USA, London, LONDO, Regno Unito
Valutazione del venditore 5 su 5 stelle
EUR 56,50
Spedizione gratuita
Spedito da Regno Unito a U.S.A.Quantità: 1 disponibili
Aggiungi al carrelloHardback. Condizione: New. Cancer is a major healthcare burden across the world and impacts not only the people diagnosed with various cancers but also their families, carers, and healthcare systems. With advances in the diagnosis and treatment, more people are diagnosed early and receive treatments for a disease where few treatments options were previously available. As a result, the survival of patients with cancer has steadily improved and, in most cases, patients who are not cured may receive multiple lines of treatment, often with financial consequences for the patients, insurers and healthcare systems. Although many books exist that address economic evaluation, Economic Evaluation of Cancer Drugs using Clinical Trial and Real World Data is the first unified text that specifically addresses the economic evaluation of cancer drugs. The authors discuss how to perform cost-effectiveness analyses while emphasising the strategic importance of designing cost-effectiveness into cancer trials and building robust economic evaluation models that have a higher chance of reimbursement if truly cost-effective. They cover the use of real-world data using cancer registries and discuss how such data can support or complement clinical trials with limited follow up. Lessons learned from failed reimbursement attempts, factors predictive of successful reimbursement and the different payer requirements across major countries including US, Australia, Canada, UK, Germany, France and Italy are also discussed. The book includes many detailed practical examples, case studies and thought-provoking exercises for use in classroom and seminar discussions. Iftekhar Khan is a medical statistician and health economist and a lead statistician at Oxford Unviersity's Center for Statistics in Medicine. Professor Khan is also a Senior Research Fellow in Health Economics at University of Warwick and is a Senior Statistical Assessor within the Licensing Division of the UK Medicine and Health Regulation Agency. Ralph Crott is a former professor in Pharmacoeconomics at the University of Montreal in Quebec, Canada and former head of the EORTC Health Economics Unit and former senior health economist at the Belgian HTA organization.Zahid Bashir has over twelve years experience working in the pharmaceutical industry in medical affairs and oncology drug development where he is involved in the design and execution of oncology clinical trials and development of reimbursement dossiers for HTA submission.
-
Economic Evaluation of Cancer Drugs (Hardcover)
Lingua: Inglese
Editore: Taylor & Francis Inc, Portland, 2019
ISBN 10: 1498761305 ISBN 13: 9781498761307
Da: Grand Eagle Retail, Bensenville, IL, U.S.A.
Valutazione del venditore 5 su 5 stelle
Hardcover. Condizione: new. Hardcover. Cancer is a major healthcare burden across the world and impacts not only the people diagnosed with various cancers but also their families, carers, and healthcare systems. With advances in the diagnosis and treatment, more people are diagnosed early and receive treatments for a disease where few treatments options were previously available. As a result, the survival of patients with cancer has steadily improved and, in most cases, patients who are not cured may receive multiple lines of treatment, often with financial consequences for the patients, insurers and healthcare systems. Although many books exist that address economic evaluation, Economic Evaluation of Cancer Drugs using Clinical Trial and Real World Data is the first unified text that specifically addresses the economic evaluation of cancer drugs. The authors discuss how to perform cost-effectiveness analyses while emphasising the strategic importance of designing cost-effectiveness into cancer trials and building robust economic evaluation models that have a higher chance of reimbursement if truly cost-effective. They cover the use of real-world data using cancer registries and discuss how such data can support or complement clinical trials with limited follow up. Lessons learned from failed reimbursement attempts, factors predictive of successful reimbursement and the different payer requirements across major countries including US, Australia, Canada, UK, Germany, France and Italy are also discussed. The book includes many detailed practical examples, case studies and thought-provoking exercises for use in classroom and seminar discussions. Iftekhar Khan is a medical statistician and health economist and a lead statistician at Oxford Unviersitys Center for Statistics in Medicine. Professor Khan is also a Senior Research Fellow in Health Economics at University of Warwick and is a Senior Statistical Assessor within the Licensing Division of the UK Medicine and Health Regulation Agency. Ralph Crott is a former professor in Pharmacoeconomics at the University of Montreal in Quebec, Canada and former head of the EORTC Health Economics Unit and former senior health economist at the Belgian HTA organization.Zahid Bashir has over twelve years experience working in the pharmaceutical industry in medical affairs and oncology drug development where he is involved in the design and execution of oncology clinical trials and development of reimbursement dossiers for HTA submission. The first book on the design and analysis of not only clinical trials but also how observational non-interventional data using clinical data is applied to economic evaluation and re-imbursement in the context of Cancer. This book is a non technical exposition of economic evaluation and no knowledge of advanced statistical methods is assumed. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
-
Economic Evaluation of Cancer Drugs
Lingua: Inglese
Editore: Taylor and Francis Inc, US, 2019
ISBN 10: 1498761305 ISBN 13: 9781498761307
Hardback. Condizione: New. Cancer is a major healthcare burden across the world and impacts not only the people diagnosed with various cancers but also their families, carers, and healthcare systems. With advances in the diagnosis and treatment, more people are diagnosed early and receive treatments for a disease where few treatments options were previously available. As a result, the survival of patients with cancer has steadily improved and, in most cases, patients who are not cured may receive multiple lines of treatment, often with financial consequences for the patients, insurers and healthcare systems. Although many books exist that address economic evaluation, Economic Evaluation of Cancer Drugs using Clinical Trial and Real World Data is the first unified text that specifically addresses the economic evaluation of cancer drugs. The authors discuss how to perform cost-effectiveness analyses while emphasising the strategic importance of designing cost-effectiveness into cancer trials and building robust economic evaluation models that have a higher chance of reimbursement if truly cost-effective. They cover the use of real-world data using cancer registries and discuss how such data can support or complement clinical trials with limited follow up. Lessons learned from failed reimbursement attempts, factors predictive of successful reimbursement and the different payer requirements across major countries including US, Australia, Canada, UK, Germany, France and Italy are also discussed. The book includes many detailed practical examples, case studies and thought-provoking exercises for use in classroom and seminar discussions. Iftekhar Khan is a medical statistician and health economist and a lead statistician at Oxford Unviersity's Center for Statistics in Medicine. Professor Khan is also a Senior Research Fellow in Health Economics at University of Warwick and is a Senior Statistical Assessor within the Licensing Division of the UK Medicine and Health Regulation Agency. Ralph Crott is a former professor in Pharmacoeconomics at the University of Montreal in Quebec, Canada and former head of the EORTC Health Economics Unit and former senior health economist at the Belgian HTA organization.Zahid Bashir has over twelve years experience working in the pharmaceutical industry in medical affairs and oncology drug development where he is involved in the design and execution of oncology clinical trials and development of reimbursement dossiers for HTA submission.
-
Economic Evaluation of Cancer Drugs: Using Clinical Trial and Real-World Data (Chapman & Hall/CRC Biostatistics Series)
Da: Ria Christie Collections, Uxbridge, Regno Unito
Valutazione del venditore 5 su 5 stelle
EUR 47,68
Spedizione EUR 13,89
Spedito da Regno Unito a U.S.A.Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
-
Economic Evaluation of Cancer Drugs: Using Clinical Trial and Real-World Data (Chapman & Hall/CRC Biostatistics)
Lingua: Inglese
Editore: Chapman and Hall/CRC 2019-06-28, 2019
ISBN 10: 1498761305 ISBN 13: 9781498761307
Da: Chiron Media, Wallingford, Regno Unito
Valutazione del venditore 5 su 5 stelle
EUR 44,12
Spedizione EUR 17,96
Spedito da Regno Unito a U.S.A.Quantità: 2 disponibili
Aggiungi al carrelloHardcover. Condizione: New.
-
Economic Evaluation of Cancer Drugs : Using Clinical Trial and Real World Data
Da: GreatBookPricesUK, Woodford Green, Regno Unito
Valutazione del venditore 5 su 5 stelle
EUR 47,07
Spedizione EUR 17,39
Spedito da Regno Unito a U.S.A.Quantità: 2 disponibili
Aggiungi al carrelloCondizione: New.
-
Design & Analysis of Clinical Trials for Economic Evaluation & Reimbursement : An Applied Approach Using SAS & Stata
Libro 61 di 155: Chapman & Hall/CRC BiostatisticsDa: GreatBookPrices, Columbia, MD, U.S.A.
Valutazione del venditore 5 su 5 stelle
Condizione: As New. Unread book in perfect condition.
-
Economic Evaluation of Cancer Drugs : Using Clinical Trial and Real-world Data
Da: GreatBookPrices, Columbia, MD, U.S.A.
Valutazione del venditore 5 su 5 stelle
EUR 66,38
Spedizione EUR 2,28
Spedito in U.S.A.Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
-
Economic Evaluation of Cancer Drugs : Using Clinical Trial and Real World Data
Da: GreatBookPricesUK, Woodford Green, Regno Unito
Valutazione del venditore 5 su 5 stelle
EUR 52,09
Spedizione EUR 17,39
Spedito da Regno Unito a U.S.A.Quantità: 2 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
-
Design & Analysis of Clinical Trials for Economic Evaluation & Reimbursement : An Applied Approach Using SAS & Stata
Libro 61 di 155: Chapman & Hall/CRC BiostatisticsDa: GreatBookPrices, Columbia, MD, U.S.A.
Valutazione del venditore 5 su 5 stelle
Condizione: New.
-
Design & Analysis of Clinical Trials for Economic Evaluation & Reimbursement (Chapman & Hall/CRC Biostatistics Series)
Libro 61 di 155: Chapman & Hall/CRC BiostatisticsDa: California Books, Miami, FL, U.S.A.
Valutazione del venditore 4 su 5 stelle
EUR 73,68
Spedizione gratuita
Spedito in U.S.A.Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
-
Design & Analysis of Clinical Trials for Economic Evaluation & Reimbursement (Chapman & Hall/CRC Biostatistics Series)
Libro 61 di 155: Chapman & Hall/CRC BiostatisticsDa: Majestic Books, Hounslow, Regno Unito
Valutazione del venditore 4 su 5 stelle
EUR 67,63
Spedizione EUR 7,53
Spedito da Regno Unito a U.S.A.Quantità: 3 disponibili
Aggiungi al carrelloCondizione: New.
-
Economic Evaluation of Cancer Drugs : Using Clinical Trial and Real-world Data
Da: GreatBookPrices, Columbia, MD, U.S.A.
Valutazione del venditore 5 su 5 stelle
EUR 73,27
Spedizione EUR 2,28
Spedito in U.S.A.Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
-
Economic Evaluation of Cancer Drugs: Using Clinical Trial and Real-World Data (Chapman & Hall/CRC Biostatistics)
Da: Majestic Books, Hounslow, Regno Unito
Valutazione del venditore 4 su 5 stelle
EUR 67,86
Spedizione EUR 7,53
Spedito da Regno Unito a U.S.A.Quantità: 3 disponibili
Aggiungi al carrelloCondizione: New.
-
Economic Evaluation of Cancer Drugs: Using Clinical Trial and Real-World Data
Da: THE SAINT BOOKSTORE, Southport, Regno Unito
Valutazione del venditore 5 su 5 stelle
EUR 53,26
Spedizione EUR 22,57
Spedito da Regno Unito a U.S.A.Quantità: 2 disponibili
Aggiungi al carrelloHardback. Condizione: New. New copy - Usually dispatched within 3 working days.
-
Design and Analysis of Clinical Trials for Economic Evaluation and Reimbursement
Libro 61 di 155: Chapman & Hall/CRC BiostatisticsDa: PBShop.store US, Wood Dale, IL, U.S.A.
Valutazione del venditore 5 su 5 stelle
EUR 80,15
Spedizione gratuita
Spedito in U.S.A.Quantità: Più di 20 disponibili
Aggiungi al carrelloPAP. Condizione: New. New Book. Shipped from UK. Established seller since 2000.
-
Hardcover. Condizione: Good. Connecting readers with great books since 1972! Used textbooks may not include companion materials such as access codes, etc. May have some wear or writing/highlighting. We ship orders daily and Customer Service is our top priority!
-
Economic Evaluation of Cancer Drugs: Using Clinical Trial and Real-World Data
Da: THE SAINT BOOKSTORE, Southport, Regno Unito
Valutazione del venditore 5 su 5 stelle
EUR 66,40
Spedizione EUR 14,61
Spedito da Regno Unito a U.S.A.Quantità: 1 disponibili
Aggiungi al carrelloPaperback / softback. Condizione: New. New copy - Usually dispatched within 4 working days.
-
Economic Evaluation of Cancer Drugs: Using Clinical Trial and Real-World Data (Chapman & Hall/CRC Biostatistics)
Da: Books Puddle, New York, NY, U.S.A.
Valutazione del venditore 4 su 5 stelle
Condizione: New. 1st edition NO-PA16APR2015-KAP.
-
Design and Analysis of Clinical Trials for Economic Evaluation and Reimbursement
Libro 61 di 155: Chapman & Hall/CRC BiostatisticsDa: PBShop.store UK, Fairford, GLOS, Regno Unito
Valutazione del venditore 5 su 5 stelle
EUR 76,78
Spedizione EUR 5,82
Spedito da Regno Unito a U.S.A.Quantità: Più di 20 disponibili
Aggiungi al carrelloPAP. Condizione: New. New Book. Shipped from UK. Established seller since 2000.
-
Design & Analysis of Clinical Trials for Economic Evaluation & Reimbursement : An Applied Approach Using SAS & Stata
Libro 61 di 155: Chapman & Hall/CRC BiostatisticsDa: GreatBookPricesUK, Woodford Green, Regno Unito
Valutazione del venditore 5 su 5 stelle
EUR 66,27
Spedizione EUR 17,39
Spedito da Regno Unito a U.S.A.Quantità: 10 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
-
Economic Evaluation of Cancer Drugs : Using Clinical Trial and Real-world Data
Da: GreatBookPricesUK, Woodford Green, Regno Unito
Valutazione del venditore 5 su 5 stelle
EUR 66,38
Spedizione EUR 17,39
Spedito da Regno Unito a U.S.A.Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
-
Economic Evaluation of Cancer Drugs : Using Clinical Trial and Real-world Data
Da: GreatBookPricesUK, Woodford Green, Regno Unito
Valutazione del venditore 5 su 5 stelle
EUR 67,42
Spedizione EUR 17,39
Spedito da Regno Unito a U.S.A.Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
-
Design & Analysis of Clinical Trials for Economic Evaluation & Reimbursement: An Applied Approach Using SAS & STATA
Libro 61 di 155: Chapman & Hall/CRC BiostatisticsDa: THE SAINT BOOKSTORE, Southport, Regno Unito
Valutazione del venditore 5 su 5 stelle
EUR 71,46
Spedizione EUR 14,61
Spedito da Regno Unito a U.S.A.Quantità: 1 disponibili
Aggiungi al carrelloPaperback / softback. Condizione: New. New copy - Usually dispatched within 4 working days.
-
Design & Analysis of Clinical Trials for Economic Evaluation & Reimbursement (Chapman & Hall/CRC Biostatistics Series)
Libro 61 di 155: Chapman & Hall/CRC BiostatisticsDa: Books Puddle, New York, NY, U.S.A.
Valutazione del venditore 4 su 5 stelle
Condizione: New. 1st edition NO-PA16APR2015-KAP.
